Patrizi Sara T, Tandel Megha D, Boothroyd Derek, Simard Julia F, Hsu Joyce J
Stanford Medicine Children's Health, Palo Alto, California.
Stanford University School of Medicine, Palo Alto, California.
ACR Open Rheumatol. 2024 Aug;6(8):454-462. doi: 10.1002/acr2.11674. Epub 2024 May 2.
In 2019, the EULAR/American College of Rheumatology developed classification criteria for systemic lupus erythematosus (SLE). A positive correlation between summary score at diagnosis and SLE disease activity at five years has been noted in adult patients with lupus, but little is known among the pediatric population. We evaluated the prognostic value of higher summary scores and number of extrarenal domains at diagnosis (low/moderate number [1-5] vs high number [6-9]) to renal outcomes after one year of treatment in pediatric patients with lupus nephritis (LN).
This retrospective, single-center cohort study included 74 pediatric patients with LN. Published pediatric renal response definitions were used for our outcome measure (no, partial, and complete response). Descriptive statistics were reported, and an ordinal logistic regression estimated adjusted odds ratios (ORs) for renal response including 95% confidence intervals (CIs).
Patients with high extrarenal domains had OR 1.47 (95% CI 0.55-2.91) of having a complete renal response compared to patients with low/moderate domains. Patients with a summary score <30 had OR 1.31 (95% CI 0.50-3.44) of having a complete renal response relative to a summary score ≥30, though a larger proportion of patients with a summary score of ≥30 had no renal response after one year of treatment.
More extrarenal domains at diagnosis did not have a statistically significant impact on renal response at one year, nor did a higher summary score. However, a larger portion of patients with a summary score <30 achieved complete renal response compared to patients with a score ≥30.
2019年,欧洲抗风湿病联盟/美国风湿病学会制定了系统性红斑狼疮(SLE)的分类标准。在成年狼疮患者中,已发现诊断时的总评分与五年时的SLE疾病活动之间存在正相关,但儿科人群对此了解甚少。我们评估了狼疮性肾炎(LN)患儿诊断时较高的总评分和肾外领域数量(低/中等数量[1 - 5]与高数量[6 - 9])对治疗一年后肾脏结局的预后价值。
这项回顾性单中心队列研究纳入了74例LN患儿。我们的结局指标采用已发表的儿科肾脏反应定义(无反应、部分反应和完全反应)。报告了描述性统计数据,并通过有序逻辑回归估计了肾脏反应的调整比值比(OR),包括95%置信区间(CI)。
与肾外领域数量低/中等的患者相比,肾外领域数量高的患者获得完全肾脏反应的OR为1.47(95% CI 0.55 - 2.91)。总评分<30的患者相对于总评分≥30的患者获得完全肾脏反应的OR为1.31(95% CI 0.50 - 3.44),尽管总评分≥30的患者中有较大比例在治疗一年后无肾脏反应。
诊断时更多的肾外领域对一年后的肾脏反应没有统计学上的显著影响,较高的总评分也没有。然而,与总评分≥30的患者相比,总评分<30的患者中有更大比例实现了完全肾脏反应。